Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Dara Aisner

Concepts (414)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
66
2025
2329
5.110
 Why?
Carcinoma, Non-Small-Cell Lung
45
2025
1046
3.870
 Why?
Genetic Testing
9
2022
428
2.300
 Why?
ErbB Receptors
22
2025
603
2.280
 Why?
Mutation
41
2025
3696
2.170
 Why?
Pathology, Molecular
7
2019
25
2.060
 Why?
Oncogene Proteins, Fusion
13
2019
200
1.950
 Why?
Protein Kinase Inhibitors
26
2025
880
1.810
 Why?
High-Throughput Nucleotide Sequencing
14
2023
487
1.800
 Why?
Molecular Diagnostic Techniques
3
2020
98
1.600
 Why?
Proto-Oncogene Proteins B-raf
13
2022
212
1.420
 Why?
Neoplasms
12
2023
2463
1.390
 Why?
Proto-Oncogene Proteins
17
2018
633
1.390
 Why?
Protein-Tyrosine Kinases
12
2018
431
1.340
 Why?
Biomarkers, Tumor
18
2024
1179
1.190
 Why?
Receptor Protein-Tyrosine Kinases
10
2019
222
1.090
 Why?
DNA, Neoplasm
3
2019
159
1.090
 Why?
Antineoplastic Agents
16
2024
2042
1.080
 Why?
Proto-Oncogene Proteins p21(ras)
11
2020
259
1.030
 Why?
Drug Resistance, Neoplasm
13
2023
749
0.950
 Why?
Proto-Oncogene Proteins c-met
5
2019
74
0.930
 Why?
Colorectal Neoplasms
3
2022
751
0.830
 Why?
Acrylamides
5
2025
58
0.830
 Why?
Gene Rearrangement
13
2019
147
0.820
 Why?
Adenocarcinoma
9
2018
894
0.800
 Why?
Molecular Targeted Therapy
11
2024
385
0.760
 Why?
Ganglioglioma
4
2014
31
0.750
 Why?
Brain Neoplasms
10
2018
1172
0.750
 Why?
DNA Mutational Analysis
11
2020
385
0.720
 Why?
Aniline Compounds
4
2025
96
0.700
 Why?
Precision Medicine
4
2018
386
0.680
 Why?
Humans
122
2025
128499
0.670
 Why?
Pyrazoles
10
2018
404
0.650
 Why?
Adenocarcinoma, Mucinous
2
2022
75
0.650
 Why?
Insurance, Health, Reimbursement
1
2020
94
0.650
 Why?
Neoplasms, Muscle Tissue
1
2019
5
0.640
 Why?
Immunohistochemistry
10
2023
1668
0.640
 Why?
Prognosis
14
2024
3780
0.640
 Why?
Receptors, Nerve Growth Factor
1
2019
17
0.640
 Why?
Biological Products
1
2022
199
0.630
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1562
0.630
 Why?
Astrocytoma
3
2015
121
0.620
 Why?
Neoplasm Metastasis
10
2024
610
0.620
 Why?
Insurance Coverage
1
2020
219
0.600
 Why?
In Situ Hybridization, Fluorescence
13
2019
313
0.570
 Why?
Laboratory Proficiency Testing
2
2023
8
0.570
 Why?
Computational Biology
4
2023
597
0.550
 Why?
RNA
5
2019
881
0.500
 Why?
Tumor Suppressor Protein p53
3
2023
508
0.490
 Why?
Small Cell Lung Carcinoma
1
2016
89
0.470
 Why?
Neoplasm Staging
13
2024
1292
0.460
 Why?
Smoking
3
2018
1459
0.450
 Why?
Aged, 80 and over
18
2025
7057
0.450
 Why?
Pyrimidines
6
2025
449
0.440
 Why?
ras Proteins
5
2015
144
0.440
 Why?
Pyridines
8
2016
474
0.430
 Why?
Mesothelioma
2
2024
38
0.430
 Why?
Neoplasm Recurrence, Local
3
2022
958
0.420
 Why?
Aged
32
2025
21976
0.400
 Why?
AMP-Activated Protein Kinases
1
2014
189
0.400
 Why?
Male
52
2025
63045
0.380
 Why?
Female
53
2025
68268
0.380
 Why?
Middle Aged
40
2025
30923
0.370
 Why?
Telomerase
7
2002
231
0.360
 Why?
TOR Serine-Threonine Kinases
1
2014
382
0.360
 Why?
S100 Proteins
2
2014
36
0.360
 Why?
Neoadjuvant Therapy
3
2024
382
0.360
 Why?
Pleural Neoplasms
2
2024
23
0.350
 Why?
Genomics
4
2023
715
0.340
 Why?
Sulfones
3
2015
108
0.320
 Why?
Curriculum
1
2016
910
0.320
 Why?
Early Detection of Cancer
2
2019
369
0.320
 Why?
Glycine
3
2015
163
0.310
 Why?
Laboratories
2
2023
109
0.310
 Why?
Adult
35
2025
35302
0.300
 Why?
Adrenal Gland Neoplasms
2
2022
84
0.290
 Why?
Head and Neck Neoplasms
3
2019
533
0.290
 Why?
Neoplasms, Multiple Primary
2
2022
54
0.280
 Why?
Treatment Outcome
12
2024
10162
0.280
 Why?
Indoles
5
2025
372
0.270
 Why?
Class I Phosphatidylinositol 3-Kinases
4
2022
81
0.270
 Why?
Oncogene Fusion
2
2019
14
0.270
 Why?
Gene Dosage
2
2018
142
0.270
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2018
52
0.270
 Why?
Exons
5
2019
339
0.260
 Why?
Antineoplastic Agents, Immunological
2
2018
177
0.260
 Why?
Survival Analysis
5
2025
1265
0.260
 Why?
Melanoma
2
2020
724
0.260
 Why?
Genetic Predisposition to Disease
6
2019
2269
0.250
 Why?
Phosphatidylinositol 3-Kinases
4
2023
357
0.250
 Why?
Oncogenes
3
2016
111
0.250
 Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb
3
2015
9
0.240
 Why?
Receptor, ErbB-2
4
2022
326
0.240
 Why?
Immunotherapy
5
2022
589
0.240
 Why?
Pemetrexed
1
2024
32
0.230
 Why?
Epithelioid Cells
2
2015
8
0.230
 Why?
Sensitivity and Specificity
5
2019
1817
0.220
 Why?
Fetomaternal Transfusion
1
2023
11
0.210
 Why?
Carcinoma, Squamous Cell
3
2019
622
0.210
 Why?
Cell Line, Tumor
11
2018
3178
0.200
 Why?
Choriocarcinoma
1
2022
9
0.200
 Why?
Endodermal Sinus Tumor
1
2022
9
0.200
 Why?
Tertiary Care Centers
1
2023
150
0.200
 Why?
Pathologists
2
2023
17
0.200
 Why?
Young Adult
13
2024
12349
0.200
 Why?
Goals
1
2023
160
0.190
 Why?
Patient Selection
4
2018
661
0.190
 Why?
Biopsy, Fine-Needle
2
2012
66
0.190
 Why?
Gene Fusion
2
2018
24
0.190
 Why?
Hematologic Neoplasms
1
2023
140
0.190
 Why?
Cell Proliferation
7
2017
2345
0.190
 Why?
Neoplasms, Germ Cell and Embryonal
1
2022
69
0.190
 Why?
Endometrial Neoplasms
1
2023
164
0.190
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
33
0.180
 Why?
Graft vs Host Disease
1
2023
239
0.180
 Why?
Biopsy
4
2018
1079
0.180
 Why?
Pheochromocytoma
1
2022
57
0.180
 Why?
Combined Modality Therapy
4
2018
1201
0.180
 Why?
Trastuzumab
1
2021
101
0.180
 Why?
Carbazoles
1
2021
84
0.180
 Why?
Meningioma
1
2022
80
0.180
 Why?
Glioblastoma
2
2015
326
0.170
 Why?
Laboratories, Hospital
1
2020
14
0.170
 Why?
United States
9
2020
13840
0.170
 Why?
Government Regulation
1
2020
49
0.170
 Why?
Pathology, Clinical
2
2017
36
0.170
 Why?
GTP Phosphohydrolases
1
2020
84
0.170
 Why?
Piperidines
1
2021
191
0.160
 Why?
Costs and Cost Analysis
1
2020
200
0.160
 Why?
Stakeholder Participation
1
2020
77
0.160
 Why?
Cell Transformation, Neoplastic
3
2018
325
0.160
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
2017
55
0.160
 Why?
Chromosome Aberrations
2
2019
149
0.160
 Why?
Genes, erbB-2
2
2015
28
0.160
 Why?
Multiplex Polymerase Chain Reaction
1
2019
51
0.150
 Why?
Smad4 Protein
1
2019
38
0.150
 Why?
Genetic Heterogeneity
1
2019
58
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Pregnancy Complications
1
2023
491
0.150
 Why?
Multigene Family
1
2019
198
0.150
 Why?
Pyridazines
1
2018
51
0.150
 Why?
Genetic Markers
1
2019
338
0.150
 Why?
Cell Cycle Proteins
4
2015
581
0.150
 Why?
Database Management Systems
1
2018
48
0.150
 Why?
Piperazines
2
2018
333
0.150
 Why?
Gene Frequency
1
2019
504
0.140
 Why?
Genetic Association Studies
1
2019
361
0.140
 Why?
Thromboembolism
1
2018
111
0.140
 Why?
Quinazolines
3
2014
243
0.140
 Why?
Cell-Free Nucleic Acids
1
2018
31
0.140
 Why?
Programmed Cell Death 1 Receptor
2
2018
227
0.140
 Why?
Smokers
1
2018
138
0.140
 Why?
Skin Neoplasms
2
2020
820
0.140
 Why?
Imidazoles
1
2018
229
0.140
 Why?
Radiotherapy, Intensity-Modulated
1
2018
129
0.140
 Why?
Intraoperative Care
1
2017
45
0.140
 Why?
Leukemia, Myeloid, Acute
1
2024
592
0.140
 Why?
Gene Deletion
1
2019
370
0.140
 Why?
Retrospective Studies
11
2025
14472
0.140
 Why?
Medical Informatics
1
2018
99
0.140
 Why?
Ovarian Neoplasms
1
2022
487
0.140
 Why?
Chloroquine
1
2017
52
0.130
 Why?
B7-H1 Antigen
1
2018
190
0.130
 Why?
Small Molecule Libraries
1
2017
86
0.130
 Why?
Pleural Effusion, Malignant
1
2016
10
0.130
 Why?
Clinical Decision-Making
1
2019
302
0.130
 Why?
Coculture Techniques
1
2017
226
0.130
 Why?
Disease Progression
6
2024
2604
0.130
 Why?
RNA, Messenger
4
2018
2679
0.130
 Why?
Carcinogenesis
1
2017
213
0.130
 Why?
Sulfonamides
2
2017
495
0.130
 Why?
Proto-Oncogene Proteins c-kit
1
2016
68
0.120
 Why?
Immunity, Humoral
1
2016
118
0.120
 Why?
Codon
1
2016
86
0.120
 Why?
Neoplastic Cells, Circulating
1
2016
71
0.120
 Why?
Triple Negative Breast Neoplasms
1
2018
197
0.120
 Why?
Positron Emission Tomography Computed Tomography
1
2016
84
0.120
 Why?
Peritoneal Neoplasms
1
2016
87
0.120
 Why?
Oncogene Proteins
1
2015
52
0.120
 Why?
Protein Kinases
1
2017
308
0.120
 Why?
Signal Transduction
5
2017
4825
0.120
 Why?
Fatal Outcome
1
2016
301
0.120
 Why?
Clinical Laboratory Techniques
1
2016
93
0.120
 Why?
Practice Guidelines as Topic
2
2019
1490
0.120
 Why?
Liver Neoplasms
3
2015
637
0.120
 Why?
Sequence Analysis, RNA
1
2017
428
0.120
 Why?
Amino Acid Substitution
1
2016
281
0.120
 Why?
Medical Oncology
3
2023
272
0.120
 Why?
Hamartoma
1
2015
20
0.120
 Why?
Immunity, Cellular
1
2016
263
0.120
 Why?
Medicare
1
2020
719
0.120
 Why?
Genetic Variation
1
2019
935
0.110
 Why?
Meningeal Carcinomatosis
1
2014
8
0.110
 Why?
Pharmacogenetics
1
2016
172
0.110
 Why?
Spinal Cord Neoplasms
1
2014
39
0.110
 Why?
Autophagy
1
2017
265
0.110
 Why?
DNA Copy Number Variations
4
2018
169
0.110
 Why?
Deoxycytidine
1
2015
163
0.110
 Why?
Health Care Surveys
1
2016
558
0.110
 Why?
Speech Disorders
1
2014
34
0.110
 Why?
Paresis
1
2014
30
0.110
 Why?
Membrane Proteins
1
2020
1109
0.110
 Why?
Multimodal Imaging
1
2015
109
0.110
 Why?
Lung Transplantation
1
2016
278
0.110
 Why?
Mitogen-Activated Protein Kinases
1
2015
311
0.110
 Why?
Polymerase Chain Reaction
2
2014
1027
0.110
 Why?
Alternative Splicing
3
2017
216
0.110
 Why?
Receptor, trkA
1
2013
16
0.110
 Why?
Wnt Signaling Pathway
1
2015
166
0.110
 Why?
Tumor Cells, Cultured
5
2019
930
0.110
 Why?
Intracranial Hemorrhages
1
2014
80
0.110
 Why?
Microscopy, Electron
1
2014
419
0.110
 Why?
Dose-Response Relationship, Drug
5
2021
1951
0.110
 Why?
Positron-Emission Tomography
1
2015
283
0.100
 Why?
Sarcoma
1
2015
177
0.100
 Why?
Serine Endopeptidases
1
2013
118
0.100
 Why?
Societies, Medical
4
2018
744
0.100
 Why?
Graft Rejection
1
2016
557
0.100
 Why?
Brain Stem Neoplasms
1
2013
89
0.100
 Why?
Headache
1
2014
149
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2017
941
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2019
1349
0.100
 Why?
Bone Neoplasms
1
2015
231
0.100
 Why?
Tissue Fixation
1
2012
34
0.100
 Why?
Microtubule-Associated Proteins
1
2013
189
0.100
 Why?
Recombinant Fusion Proteins
2
2013
636
0.100
 Why?
Predictive Value of Tests
2
2015
1938
0.100
 Why?
Gene Amplification
3
2019
104
0.100
 Why?
Lung
4
2015
3748
0.100
 Why?
Mutation Rate
1
2011
25
0.090
 Why?
Education, Medical, Graduate
1
2016
435
0.090
 Why?
Translocation, Genetic
1
2012
97
0.090
 Why?
Algorithms
1
2019
1614
0.090
 Why?
Tomography, X-Ray Computed
3
2018
2517
0.090
 Why?
Interdisciplinary Communication
1
2012
185
0.090
 Why?
Specimen Handling
1
2012
163
0.090
 Why?
Teratoma
1
2011
105
0.090
 Why?
Epithelial Cells
1
2017
1043
0.090
 Why?
Terminology as Topic
1
2012
199
0.090
 Why?
Rhabdoid Tumor
1
2011
98
0.090
 Why?
Prospective Studies
2
2023
7069
0.090
 Why?
DNA-Binding Proteins
6
2011
1423
0.080
 Why?
Genome, Human
1
2012
392
0.080
 Why?
Breast Neoplasms
1
2022
2135
0.080
 Why?
Xenograft Model Antitumor Assays
3
2019
812
0.080
 Why?
Phosphorylation
1
2014
1686
0.080
 Why?
Immunoenzyme Techniques
3
2015
205
0.080
 Why?
Erlotinib Hydrochloride
3
2014
69
0.080
 Why?
Survival Rate
4
2019
1871
0.080
 Why?
Disease-Free Survival
3
2016
647
0.080
 Why?
Catheter Ablation
1
2012
334
0.080
 Why?
Telomere
3
2000
227
0.080
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2008
13
0.070
 Why?
beta Catenin
2
2023
218
0.070
 Why?
Hematopoietic Stem Cell Transplantation
2
2024
575
0.070
 Why?
Proto-Oncogene Proteins c-ret
2
2018
30
0.070
 Why?
Diagnosis, Differential
1
2012
1412
0.070
 Why?
Follow-Up Studies
4
2021
4874
0.070
 Why?
Maximum Tolerated Dose
2
2021
192
0.070
 Why?
Heart Neoplasms
1
2008
49
0.070
 Why?
Pancreatic Neoplasms
1
2015
878
0.070
 Why?
Adolescent
6
2019
20304
0.070
 Why?
DNA
1
2014
1394
0.070
 Why?
Reproducibility of Results
3
2019
3021
0.070
 Why?
Workflow
2
2017
154
0.060
 Why?
Internship and Residency
1
2016
1045
0.060
 Why?
Eye Neoplasms
1
2005
16
0.060
 Why?
Mental Disorders
1
2014
1007
0.060
 Why?
Pleura
1
2024
22
0.060
 Why?
Immunophenotyping
1
2005
309
0.060
 Why?
Administration, Oral
2
2018
767
0.060
 Why?
Induction Chemotherapy
1
2024
70
0.050
 Why?
Poly-ADP-Ribose Binding Proteins
1
2023
33
0.050
 Why?
DNA Polymerase II
1
2023
38
0.050
 Why?
Peritoneum
1
2023
41
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2015
324
0.050
 Why?
Genes, ras
2
2015
97
0.050
 Why?
DNA Mismatch Repair
1
2023
47
0.050
 Why?
Antigens, Differentiation, B-Lymphocyte
2
2013
37
0.050
 Why?
Leukocyte Count
1
2024
326
0.050
 Why?
Blotting, Western
4
2015
1170
0.050
 Why?
Carcinoma, Endometrioid
1
2022
47
0.050
 Why?
Cell Cycle
2
2012
581
0.050
 Why?
Cell Survival
2
2017
1076
0.050
 Why?
Magnetic Resonance Imaging
1
2014
3387
0.050
 Why?
Active Transport, Cell Nucleus
1
2002
112
0.050
 Why?
Clinical Trials as Topic
2
2017
1003
0.050
 Why?
Histocompatibility Antigens Class II
2
2013
360
0.050
 Why?
Gene Expression Regulation, Enzymologic
1
2002
283
0.040
 Why?
Gene Expression Profiling
2
2017
1689
0.040
 Why?
Models, Molecular
2
2018
1484
0.040
 Why?
Standard of Care
1
2020
72
0.040
 Why?
Base Sequence
3
2017
2137
0.040
 Why?
Protein Processing, Post-Translational
1
2002
453
0.040
 Why?
Time Factors
3
2020
6506
0.040
 Why?
HSP90 Heat-Shock Proteins
1
1999
45
0.040
 Why?
Fetus
1
2023
765
0.040
 Why?
Tumor Microenvironment
1
2023
624
0.040
 Why?
Cell Nucleus
1
2002
580
0.040
 Why?
Catalytic Domain
4
2000
217
0.040
 Why?
Sequence Deletion
2
2014
178
0.040
 Why?
Cohort Studies
2
2019
5402
0.040
 Why?
Radiotherapy, Image-Guided
1
2018
33
0.040
 Why?
Aurora Kinase A
1
2018
55
0.040
 Why?
Cell Line
4
2012
2741
0.040
 Why?
RNA, Untranslated
1
1999
114
0.040
 Why?
Proto-Oncogenes
1
2018
29
0.040
 Why?
Phthalazines
1
2018
41
0.040
 Why?
Nausea
1
2018
108
0.040
 Why?
Cetuximab
1
2018
93
0.040
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2017
24
0.040
 Why?
Breast
1
2018
152
0.040
 Why?
Diarrhea
1
2018
180
0.030
 Why?
Child
5
2015
20805
0.030
 Why?
Quality Control
1
2017
157
0.030
 Why?
A549 Cells
1
2017
57
0.030
 Why?
Molecular Sequence Data
3
2013
2822
0.030
 Why?
Structure-Activity Relationship
1
2018
539
0.030
 Why?
Pathology, Surgical
1
2016
8
0.030
 Why?
Fatigue
1
2018
316
0.030
 Why?
Centrosome
1
2016
64
0.030
 Why?
Drug Synergism
1
2017
357
0.030
 Why?
Carcinoma
2
2012
215
0.030
 Why?
Dual Specificity Phosphatase 6
1
2015
6
0.030
 Why?
Transcription, Genetic
1
2002
1404
0.030
 Why?
Genes, erbB-1
1
2015
17
0.030
 Why?
Child, Preschool
3
2015
10487
0.030
 Why?
Mice, Nude
1
2017
678
0.030
 Why?
Lamin Type A
1
2015
48
0.030
 Why?
Cell Line, Transformed
3
2000
141
0.030
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
131
0.030
 Why?
MAP Kinase Kinase 1
1
2015
76
0.030
 Why?
Multivariate Analysis
1
2018
1499
0.030
 Why?
Antimetabolites, Antineoplastic
1
2015
91
0.030
 Why?
Consensus
1
2018
610
0.030
 Why?
HEK293 Cells
1
2017
683
0.030
 Why?
Sequence Analysis, DNA
1
2017
775
0.030
 Why?
Respiratory Mucosa
1
2017
304
0.030
 Why?
Radiopharmaceuticals
1
2015
166
0.030
 Why?
Fluorodeoxyglucose F18
1
2015
127
0.030
 Why?
Recurrence
1
2017
1004
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
372
0.030
 Why?
Animals
5
2019
34647
0.030
 Why?
Microdissection
1
2013
15
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2018
758
0.030
 Why?
Epidermal Growth Factor
1
2013
170
0.030
 Why?
Drug Administration Schedule
1
2015
764
0.030
 Why?
Disease Management
1
2017
584
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2015
420
0.030
 Why?
Syndecan-4
1
2012
7
0.030
 Why?
Papillomaviridae
1
2013
113
0.030
 Why?
Randomized Controlled Trials as Topic
1
2018
1358
0.020
 Why?
Cooperative Behavior
1
2015
424
0.020
 Why?
Transcriptome
1
2018
883
0.020
 Why?
Bone and Bones
1
2015
298
0.020
 Why?
SMARCB1 Protein
1
2011
29
0.020
 Why?
Incidence
1
2018
2638
0.020
 Why?
Hyperglycemia
1
2015
326
0.020
 Why?
Green Fluorescent Proteins
1
2012
380
0.020
 Why?
Mice
2
2019
16620
0.020
 Why?
Chromosomal Proteins, Non-Histone
1
2011
115
0.020
 Why?
Lymphatic Metastasis
1
2012
317
0.020
 Why?
Pregnancy
1
2023
6373
0.020
 Why?
Adaptor Proteins, Signal Transducing
1
2013
392
0.020
 Why?
Bronchoscopy
1
2012
208
0.020
 Why?
Infant
2
2015
9001
0.020
 Why?
Enzyme Inhibitors
1
2014
813
0.020
 Why?
Cognition Disorders
1
2014
498
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2064
0.020
 Why?
Papillomavirus Infections
1
2013
293
0.020
 Why?
Retroviridae
2
2000
99
0.020
 Why?
Reticulocytes
2
1999
18
0.020
 Why?
Protein Structure, Tertiary
1
2012
837
0.020
 Why?
Hypertension
1
2018
1236
0.020
 Why?
Cells, Cultured
1
2017
4017
0.020
 Why?
Sex Factors
1
2015
1951
0.020
 Why?
Genetic Vectors
2
2000
311
0.020
 Why?
Leukemic Infiltration
1
2008
5
0.020
 Why?
DNA Primers
2
1999
510
0.020
 Why?
Human T-lymphotropic virus 1
1
2008
28
0.020
 Why?
Longitudinal Studies
1
2015
2710
0.020
 Why?
Rabbits
2
1999
775
0.020
 Why?
T-Lymphocytes
1
2016
1923
0.020
 Why?
National Institutes of Health (U.S.)
1
2008
122
0.020
 Why?
In Vitro Techniques
2
1999
1047
0.020
 Why?
Phenotype
1
2015
3051
0.020
 Why?
Apoptosis
1
2015
2437
0.020
 Why?
Biomarkers
1
2017
3893
0.020
 Why?
Fibroblasts
2
2000
937
0.010
 Why?
Transcription Factors
1
2011
1635
0.010
 Why?
Infant, Newborn
1
2013
5740
0.010
 Why?
Peptide Chain Termination, Translational
1
2000
5
0.010
 Why?
Fetal Proteins
1
2000
16
0.010
 Why?
Genes, Dominant
1
2000
91
0.010
 Why?
Chromosomes, Human
1
2000
41
0.010
 Why?
Fibrosarcoma
1
2000
20
0.010
 Why?
DNA, Complementary
1
2000
267
0.010
 Why?
Protein Subunits
1
2000
230
0.010
 Why?
Quinones
1
1999
10
0.010
 Why?
RNA-Directed DNA Polymerase
1
1999
34
0.010
 Why?
Lactams, Macrocyclic
1
1999
49
0.010
 Why?
Benzoquinones
1
1999
47
0.010
 Why?
Cyclosporine
1
1999
171
0.010
 Why?
Transfection
1
2000
896
0.010
 Why?
Carcinoma, Renal Cell
1
2000
180
0.010
 Why?
Molecular Chaperones
1
1999
182
0.010
 Why?
Half-Life
1
1997
152
0.010
 Why?
Neoplasm Proteins
1
2000
420
0.010
 Why?
RNA, Long Noncoding
1
1999
178
0.010
 Why?
Adenosine Triphosphate
1
1999
469
0.010
 Why?
Recombinant Proteins
1
1999
1291
0.010
 Why?
Skin
1
2000
717
0.010
 Why?
Flow Cytometry
1
1997
1142
0.010
 Why?
Prostatic Neoplasms
1
2000
1016
0.010
 Why?
Aisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (414) concept(s)
_
Co-Authors Expand Description
See all (86) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)